JP Morgan Chase’s Strata Skin Sciences SSKN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-46
Closed -$121 7610
2025
Q1
$121 Sell
46
-60
-57% -$167 ﹤0.01% 6856
2024
Q4
$306 Hold
106
﹤0.01% 6858
2024
Q3
$292 Buy
106
+1
+1% +$3 ﹤0.01% 6858
2024
Q2
$322 Buy
105
+50
+91% +$203 ﹤0.01% 6731
2024
Q1
$208 Sell
55
-8
-13% -$42 ﹤0.01% 6807
2023
Q4
$349 Buy
63
+60
+2,000% +$312 ﹤0.01% 6974
2023
Q3
$15 Buy
+3
New +$23 ﹤0.01% 7235
2020
Q4
Sell
-1
Closed 5914
2020
Q3
$0 Hold
1
﹤0.01% 5753
2020
Q2
$0 Buy
+1
New +$12 ﹤0.01% 5684
2020
Q1
Sell
-12
Closed 5702
2019
Q4
$0 Hold
12
﹤0.01% 5876
2019
Q3
$0 Hold
12
﹤0.01% 5944
2019
Q2
$0 Hold
12
﹤0.01% 6000
2019
Q1
$0 Hold
12
﹤0.01% 6028
2018
Q4
$0 Buy
+12
New +$343 ﹤0.01% 5933

Other funds holding SSKN

JP Morgan Chase's SSKN Position: Q2 2025 in Review

JP Morgan Chase sold out of Strata Skin Sciences (SSKN) in Q2 2025, closing a stake of 46 shares — an estimated $121 sold.

JP Morgan Chase first reported a position in SSKN in Q4 2018 and held it in 14 quarters. The position peaked at $349 in Q4 2023. 16 funds tracked by Wall St. Rank hold SSKN as of Q2 2025.

  • JP Morgan Chase reported no remaining Strata Skin Sciences position as of Q2 2025 after selling out during the quarter.
  • JP Morgan Chase sold 46 Strata Skin Sciences shares in Q2 2025, an estimated $121.
  • JP Morgan Chase first reported a position in Strata Skin Sciences in Q4 2018 and held it in 14 quarters.
  • JP Morgan Chase's Strata Skin Sciences position peaked at $349 in Q4 2023.
  • 16 funds tracked by Wall St. Rank held Strata Skin Sciences as of Q2 2025.

Based on JP Morgan Chase's 13F filing for Q2 2025, filed 12 Aug 2025.